News
Needham has upgraded Boston Scientific to a Buy, setting a new $113 target based on strengthened growth potential and less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback